![Restoration of Li+ pathways in the [010] direction during direct regeneration for spent LiFePO4](http://pubs.rsc.org/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5EE00641D)
.jpg)
Nanobiotix tweaks J&J licensing deal for phase 3 cancer drug to eke out cash
Nanobiotix has tweaked the terms of a licensing deal with Johnson & Johnson over the French biotech’s phase 3-stage cancer drug in order to keep the cash flowing through to next year.
Nanobiotix has tweaked the terms of a licensing deal with Johnson & Johnson over the French biotech’s phase 3-stage cancer drug in order to keep the cash flowing through to next year.
